Review and critical appraisal of the indications for cardiac magnetic resonance imaging in the ESC guidelines

References

• Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477. doi:10.1093/eurheartj/ehz425.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. doi:10.1093/eurheartj/ehac262.
   PubMed Web of Science ®Google Scholar
• Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(37):3503–3626. doi:10.1093/eurheartj/ehad194.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269. doi:10.1093/eurheartj/ehy462.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393.
   PubMed Web of Science ®Google Scholar
• Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44(11):2166–2172. doi:10.1016/j.jacc.2004.08.054.
   PubMed Web of Science ®Google Scholar
• Ibanez B, Aletras AH, Arai AE, et al. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. J Am Coll Cardiol. 2019;74(2):238–256. doi:10.1016/j.jacc.2019.05.024.
   PubMed Web of Science ®Google Scholar
• Roifman I, Connelly KA, Wright GA, et al. Echocardiography vs. Cardiac magnetic resonance imaging for the diagnosis of left ventricular thrombus: a systematic review. Can J Cardiol. 2015;31(6):785–791. doi:10.1016/j.cjca.2015.01.011.
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575.
   PubMed Web of Science ®Google Scholar
• Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158–3176. doi:10.1016/j.jacc.2018.09.072.
   PubMed Web of Science ®Google Scholar
• Tornvall P, Gerbaud E, Behaghel A, et al. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: a meta-analysis of individual patient data. Atherosclerosis. 2015;241(1):87–91. doi:10.1016/j.atherosclerosis.2015.04.816.
   PubMed Web of Science ®Google Scholar
• Mileva N, Paolisso P, Gallinoro E, et al. Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis. JACC Cardiovasc Imaging. 2023;16(3):376–389. doi:10.1016/j.jcmg.2022.12.029.
   PubMed Web of Science ®Google Scholar
• Williams MGL, Liang K, De Garate E, et al. Peak troponin and cMR to guide management in suspected ACS and nonobstructive coronary arteries. JACC Cardiovasc Imaging. 2022;15(9):1578–1587. doi:10.1016/j.jcmg.2022.03.017.
   PubMed Web of Science ®Google Scholar
• Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379(9814):453–460. doi:10.1016/S0140-6736(11)61335-4.
   PubMed Web of Science ®Google Scholar
• Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA. 2016;316(10):1051–1060. doi:10.1001/jama.2016.12680.
   PubMed Web of Science ®Google Scholar
• Nagel E, Greenwood JP, McCann GP, et al. Magnetic resonance perfusion or fractional flow reserve in coronary disease. N Engl J Med. 2019;380(25):2418–2428. doi:10.1056/NEJMoa1716734.
   PubMed Web of Science ®Google Scholar
• Pezel T, Hovasse T, Kinnel M, et al. Long-Term prognostic value of stress cardiovascular magnetic resonance in patients with history of percutaneous coronary intervention. Circ Cardiovasc Imaging. 2021;14:e012374.
   PubMed Web of Science ®Google Scholar
• Pezel T, Sanguineti F, Kinnel M, et al. Safety and prognostic value of vasodilator stress cardiovascular magnetic resonance in patients with heart failure and reduced ejection fraction. Circ Cardiovasc Imaging. 2020;13:e010599.
   PubMed Web of Science ®Google Scholar
• Pezel T, Unterseeh T, Garot P, et al. Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing. J Cardiovasc Magn Reson. 2021;23(1):89. doi:10.1186/s12968-021-00785-6.
   PubMed Web of Science ®Google Scholar
• Pezel T, Lacotte J, Horvilleur J, et al. Safety, feasibility, and prognostic value of stress perfusion cMR in patients with MR-conditional pacemaker. Eur Heart J Cardiovasc Imaging. 2023;24(2):202–211. doi:10.1093/ehjci/jeac202.
   PubMed Web of Science ®Google Scholar
• Knuuti J, Ballo H, Juarez-Orozco LE, et al. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J. 2018;39(35):3322–3330. doi:10.1093/eurheartj/ehy267.
   PubMed Web of Science ®Google Scholar
• Patel AR, Salerno M, Kwong RY, et al. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. J Am Coll Cardiol. 2021;78(16):1655–1668. doi:10.1016/j.jacc.2021.08.022.
   PubMed Web of Science ®Google Scholar
• Franks R, Plein S, Chiribiri A. Clinical application of dynamic contrast enhanced perfusion imaging by cardiovascular magnetic resonance. Front Cardiovasc Med. 2021;8:768563. doi:10.3389/fcvm.2021.768563.
   PubMed Web of Science ®Google Scholar
• Almeida AG, Carpenter JP, Cameli M, et al. Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2021;22(8):e97–e125. doi:10.1093/ehjci/jeab053.
   PubMed Web of Science ®Google Scholar
• Menghoum N, Vos JL, Pouleur AC, et al. How to evaluate cardiomyopathies by cardiovascular magnetic resonance parametric mapping and late gadolinium enhancement. Eur Heart J Cardiovasc Imaging. 2022;23(5):587–589. doi:10.1093/ehjci/jeac051.
   PubMed Web of Science ®Google Scholar
• Becker MAJ, Cornel JH, van de Ven PM, et al. The prognostic value of late Gadolinium-Enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and Meta-Analysis. JACC Cardiovasc Imaging. 2018;11(9):1274–1284. doi:10.1016/j.jcmg.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221–1230. doi:10.1056/NEJMoa1608029.
   PubMed Web of Science ®Google Scholar
• Petersen SE, Jensen B, Aung N, et al. Excessive trabeculation of the left ventricle: JACC: cardiovascular imaging expert panel paper. JACC Cardiovasc Imaging. 2023;16(3):408–425. doi:10.1016/j.jcmg.2022.12.026.
   PubMed Web of Science ®Google Scholar
• Kamp NJ, Chery G, Kosinski AS, et al. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Prog Cardiovasc Dis. 2021;66:10–16. doi:10.1016/j.pcad.2020.11.001.
   PubMed Web of Science ®Google Scholar
• Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533–1541. doi:10.1161/CIRCULATIONAHA.108.840827.
   PubMed Web of Science ®Google Scholar
• Aquaro GD, Pingitore A, Strata E, et al. Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology. J Am Coll Cardiol. 2010;56(15):1235–1243. doi:10.1016/j.jacc.2010.03.087.
   PubMed Web of Science ®Google Scholar
• Rodrigues P, Joshi A, Williams H, et al. Diagnosis and prognosis in sudden cardiac arrest survivors without coronary artery disease: utility of a clinical approach using cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2017;10:e006709.
   PubMed Web of Science ®Google Scholar
• Neilan TG, Farhad H, Mayrhofer T, et al. Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging. 2015;8(4):414–423. doi:10.1016/j.jcmg.2014.11.017.
   PubMed Web of Science ®Google Scholar
• White JA, Fine NM, Gula L, et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging. 2012;5(1):12–20. doi:10.1161/CIRCIMAGING.111.966085.
   PubMed Web of Science ®Google Scholar
• Lindemann F, Oebel S, Paetsch I, et al. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms. J Cardiovasc Magn Reson. 2020;22(1):32. doi:10.1186/s12968-020-00609-z.
   PubMed Web of Science ®Google Scholar
• Patel HN, Wang S, Rao SN, et al. Impact of wideband cardiac magnetic resonance on diagnosis, decision-making, and outcomes in patients with ICD. Eur Heart J Cardiovasc Imaging. 2022;24(2):181–189.
   Web of Science ®Google Scholar
• Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506. doi:10.1001/jama.2014.3.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Wazni O, McGann C, et al. Effect of MRI-Guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial. JAMA. 2022;327(23):2296–2305. doi:10.1001/jama.2022.8831.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Pibarot P, Chambers J, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022;23(5):e171–e232. doi:10.1093/ehjci/jeab253.
   PubMed Web of Science ®Google Scholar
• Kammerlander AA, Wiesinger M, Duca F, et al. Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC Cardiovasc Imaging. 2019;12(8 Pt 1):1474–1483. doi:10.1016/j.jcmg.2018.08.036.
   Google Scholar
• Penicka M, Vecera J, Mirica DC, et al. Prognostic implications of magnetic Resonance-Derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with Doppler echocardiography-derived integrative approach. Circulation. 2018;137(13):1349–1360. doi:10.1161/CIRCULATIONAHA.117.029332.
   PubMed Web of Science ®Google Scholar
• Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–2964. doi:10.1093/eurheartj/ehv318.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. doi:10.1093/eurheartj/ehaa554.
   PubMed Web of Science ®Google Scholar